Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3
about
Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylationRole of insulin-like growth factor binding protein-3 in breast cancer cell growthAnalysis of the cellular uptake and nuclear delivery of insulin-like growth factor binding protein-3 in human osteosarcoma cellsHuman papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner.Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3Activation of various downstream signaling molecules by IGFBP-3.Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ.Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).Analysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peripheral blood cells and cervical tissue samples of females with cervical intraepithelial lesions and squamous cervical cancer.Functional inactivation of pRB results in aneuploid mammalian cells after release from a mitotic block.Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteinsRole of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.The papillomavirus E7 proteins.Biomarkers in cervical cancerOncogenic activities of human papillomaviruses.The human papillomavirus E7 oncoprotein.Perspectives in mammalian IGFBP-3 biology: local vs. systemic action.The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication.E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis.Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis.The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc-finger protein-1.Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylationNonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus.The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex.Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells.Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77.Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7.The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2.Recurrent respiratory papillomatosis
P2860
Q24800130-692E0D46-99B8-4A30-96E8-FEEC73023275Q28202893-F48D2408-7399-4280-A149-F4EFE4F3800FQ28236310-CA755C3A-B3AA-4EB6-8BB9-85CC7BEB29BFQ33292435-A600FA91-4C66-425A-B43C-4B83A2EE1252Q34073234-469A6DC3-08B3-4A9E-A5FF-4A9007555C00Q34219109-6DA595EA-44FF-4B2E-B1E3-18A77354E2FDQ34411810-942FA0E1-EE28-4884-A7E8-830ACEF8D9C5Q34468787-42A81967-1BD9-466A-B533-C170C52A7D25Q34556695-8E0A0960-0164-43EA-B829-8F4964A2C224Q34673597-7DE6F268-D081-4FFF-961F-43D8F75A6573Q35166884-66A899CA-2E11-4A04-8788-C5B814982ECFQ35545566-8A9B5058-B84B-456B-88F3-8479156E2F63Q35747623-1661B8E8-8639-4781-B5B6-B94BD3976C4EQ37002546-F0FA7C92-0F89-49FA-9948-0BAB169DB971Q37198662-C5EDB772-14EA-4FEA-9EFF-AE9189B2CC74Q37277976-948035E3-79C8-4F10-A172-903C96DD47DCQ37316158-CC83D0F2-5862-4FB5-B083-161A6D153F0BQ37325199-AF51D461-D894-4032-8A22-67FE0B74DAE9Q37412844-5DACC49C-1B8D-4CC1-9C55-9D799FB81F10Q37808166-16143105-465E-47FC-A8C1-34A6D5042FF0Q38180349-E39344B2-D292-42AB-85D7-D6892B16F54BQ38304904-0D9D92C9-E364-4B8A-A3DF-CEBFD9C7A038Q39440454-1CD9D77E-384A-41D8-9536-2D6D0C2ED8BCQ39833101-37401C34-DB0F-4CCE-B91F-63595FBCC6B5Q40263710-F82CE339-C90A-4FC6-BBF3-6203BB33ED04Q40734787-6EA6E3F8-86EE-465B-AC4B-339BB980A7C9Q40751988-213FC253-295A-45EF-AD6B-59A0A9C07334Q45282577-02D64EC2-B7A9-465B-A567-EB317749B3B5Q45417338-75745313-B1C2-42DB-BAE0-CA54E2709543Q46077526-69ECB06A-49C5-4192-9918-1376B7CF2CD0Q55982769-71CF6277-879E-4547-ADBF-465547E18846
P2860
Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Human papillomavirus type 16 E ...... rowth factor binding protein 3
@en
Human papillomavirus type 16 E ...... owth factor binding protein 3.
@nl
type
label
Human papillomavirus type 16 E ...... rowth factor binding protein 3
@en
Human papillomavirus type 16 E ...... owth factor binding protein 3.
@nl
prefLabel
Human papillomavirus type 16 E ...... rowth factor binding protein 3
@en
Human papillomavirus type 16 E ...... owth factor binding protein 3.
@nl
P2093
P2860
P1476
Human papillomavirus type 16 E ...... rowth factor binding protein 3
@en
P2093
B Mannhardt
P Jansen-Dürr
S A Weinzimer
W Zwerschke
P2860
P304
P356
10.1128/MCB.20.17.6483-6495.2000
P407
P577
2000-09-01T00:00:00Z